Effect of TDCS in treatment of fibromyalgia
Not Applicable
- Conditions
- Fibromyalgia.Fibromyalgia
- Registration Number
- IRCT20180220038802N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
American college of rheumatology 's criteria for fibromyalgia
Age >18
VAS >=4 (1week before study)
Exclusion Criteria
The patient desire to leave the study at each stage of the plan
major depression ( beck score>30) or psychosis
Diseases that disrupts the process ,such as diagnosed DM ,heart ,liver , pulmonary or kidney diseases
Pregnancy and lactation
Metal implant
History of seizure or epilepsy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of pain. Timepoint: Zero, The last day of treatment, 6 and 12 weeks later. Method of measurement: Visual analog scale (vas).;The quality of life. Timepoint: Zero ,6 and 12 weeks later. Method of measurement: By SF36 questionnare.;The depression and anxiety. Timepoint: Zero, 6 and 12 weeks later. Method of measurement: DASS questionnare.;Health condition in fibromyalgia. Timepoint: Zero, 6 and 12 weeks later. Method of measurement: FIQ questionnare.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: 6 and 12 weeks later. Method of measurement: Physical exam.